^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    humanized CD19 CAR-T cell therapy

    i
    Other names: humanized CD19 CAR-T cell therapy, humanized CD19 CAR-T cells therapy
    Associations

    News

    Trials
    Company:
    Shanghai Yake Biotech
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    4years
    A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL (clinicaltrials.gov)
    P1, N=72, Recruiting, Zhejiang University
    Clinical • New P1 trial • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule)
    |
    humanized CD19 CAR-T cell therapy